Profound Medical Net Worth
Profound Medical Net Worth Breakdown | PROF |
Profound Medical Net Worth Analysis
Profound Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Profound Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Profound Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Profound Medical's net worth analysis. One common approach is to calculate Profound Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Profound Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Profound Medical's net worth. This approach calculates the present value of Profound Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Profound Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Profound Medical's net worth. This involves comparing Profound Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Profound Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Profound Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Profound Medical's net worth research are outlined below:
| Profound Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 7.04 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Profound Medical has a frail financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Profound Medical Corp. Investors Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation |
Profound Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Profound Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Profound Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Profound Medical Target Price Consensus
Profound target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Profound Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Profound analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Profound stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Profound Medical Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationProfound Medical Target Price Projection
Profound Medical's current and average target prices are 6.81 and 15.30, respectively. The current price of Profound Medical is the price at which Profound Medical Corp is currently trading. On the other hand, Profound Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Profound Medical Market Quote on 22nd of March 2025
Target Price
Analyst Consensus On Profound Medical Target Price
Know Profound Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Profound Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Profound Medical Corp backward and forwards among themselves. Profound Medical's institutional investor refers to the entity that pools money to purchase Profound Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-12-31 | 421.2 K | Ardsley Advisory Partners | 2024-12-31 | 295 K | Ring Mountain Capital, Llc | 2024-12-31 | 277.9 K | Picton Mahoney Asset Management | 2024-12-31 | 250 K | Formula Growth Ltd | 2024-12-31 | 250 K | Bank Of America Corp | 2024-12-31 | 202.6 K | Stonepine Capital Management Llc | 2024-12-31 | 200 K | Bleichroeder Lp | 2024-12-31 | 183.3 K | Thompson Davis & Co Inc | 2024-12-31 | 182.3 K | Fidelity International Ltd | 2024-12-31 | 1.8 M | Gagnon Securities Llc | 2024-12-31 | 1.7 M |
Follow Profound Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 208.48 M.Market Cap |
|
Project Profound Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (0.46) | (0.48) |
When accessing Profound Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Profound Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Profound Medical's profitability and make more informed investment decisions.
Evaluate Profound Medical's management efficiency
Profound Medical Corp has return on total asset (ROA) of (0.3619) % which means that it has lost $0.3619 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.607) %, meaning that it created substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.42. The current Return On Capital Employed is estimated to decrease to -0.55. At this time, Profound Medical's Other Assets are most likely to increase significantly in the upcoming years. The Profound Medical's current Fixed Asset Turnover is estimated to increase to 13.66, while Total Assets are projected to decrease to roughly 49.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.44 | 3.43 | |
| Tangible Book Value Per Share | 2.43 | 3.15 | |
| Enterprise Value Over EBITDA | (4.24) | (4.45) | |
| Price Book Value Ratio | 3.08 | 3.42 | |
| Enterprise Value Multiple | (4.24) | (4.45) | |
| Price Fair Value | 3.08 | 3.42 | |
| Enterprise Value | 136.1 M | 197.4 M |
The management team at Profound Medical has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 15.0702 | Revenue | Quarterly Revenue Growth 0.844 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Profound Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Profound Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Profound Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hofer Michael over three months ago Acquisition by Hofer Michael of 500000 shares of Profound Medical at 0.0014 subject to Rule 16b-3 |
Profound Medical Corporate Filings
| 10th of March 2025 Other Reports | ViewVerify | |
8K | 7th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 23rd of January 2025 Other Reports | ViewVerify | |
6K | 6th of January 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Profound Medical Earnings Estimation Breakdown
The calculation of Profound Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Profound Medical is estimated to be -0.2825 with the future projection ranging from a low of -0.31 to a high of -0.26. Please be aware that this consensus of annual earnings estimates for Profound Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.31 Lowest | Expected EPS | -0.26 Highest |
Profound Medical Earnings Projection Consensus
Suppose the current estimates of Profound Medical's value are higher than the current market price of the Profound Medical stock. In this case, investors may conclude that Profound Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Profound Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 5 | 75.69% | -0.2 | -0.2825 | -1.12 |
Profound Medical Earnings History
Earnings estimate consensus by Profound Medical Corp analysts from Wall Street is used by the market to judge Profound Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Profound Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Profound Medical Quarterly Gross Profit |
|
Profound Medical Earnings per Share Projection vs Actual
Actual Earning per Share of Profound Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Profound Medical Corp predict the company's earnings will be in the future. The higher the earnings per share of Profound Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Profound Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Profound Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Profound Medical should always be considered in relation to other companies to make a more educated investment decision.Profound Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Profound Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-03-05 | 2024-12-31 | -0.3225 | -0.2 | 0.1225 | 37 | ||
2024-11-07 | 2024-09-30 | -0.3 | -0.38 | -0.08 | 26 | ||
2024-08-08 | 2024-06-30 | -0.29 | -0.28 | 0.01 | 3 | ||
2024-05-09 | 2024-03-31 | -0.3 | -0.26 | 0.04 | 13 | ||
2024-03-07 | 2023-12-31 | -0.32 | -0.42 | -0.1 | 31 | ||
2023-11-02 | 2023-09-30 | -0.33 | -0.26 | 0.07 | 21 | ||
2023-08-09 | 2023-06-30 | -0.34 | -0.35 | -0.01 | 2 | ||
2023-05-10 | 2023-03-31 | -0.34 | -0.32 | 0.02 | 5 | ||
2023-03-07 | 2022-12-31 | -0.36 | -0.46 | -0.1 | 27 | ||
2022-11-03 | 2022-09-30 | -0.38 | -0.24 | 0.14 | 36 | ||
2022-08-04 | 2022-06-30 | -0.4 | -0.28 | 0.12 | 30 | ||
2022-05-09 | 2022-03-31 | -0.43 | -0.4 | 0.03 | 6 | ||
2022-03-03 | 2021-12-31 | -0.37 | -0.49 | -0.12 | 32 | ||
2021-11-04 | 2021-09-30 | -0.28 | -0.29 | -0.01 | 3 | ||
2021-08-04 | 2021-06-30 | -0.28 | -0.35 | -0.07 | 25 | ||
2021-05-12 | 2021-03-31 | -0.27 | -0.37 | -0.1 | 37 | ||
2021-03-02 | 2020-12-31 | -0.43 | -0.49 | -0.06 | 13 | ||
2020-11-05 | 2020-09-30 | -0.35 | -0.43 | -0.08 | 22 | ||
2020-08-06 | 2020-06-30 | -0.31 | -0.46 | -0.15 | 48 | ||
2020-05-07 | 2020-03-31 | -0.33 | -0.25 | 0.08 | 24 | ||
2020-03-03 | 2019-12-31 | -0.4923 | -0.321 | 0.1713 | 34 | ||
2019-11-07 | 2019-09-30 | -0.38 | -0.43 | -0.05 | 13 | ||
2019-08-14 | 2019-06-30 | -0.33 | -0.38 | -0.05 | 15 | ||
2019-05-06 | 2019-03-31 | -0.33 | -0.22 | 0.11 | 33 | ||
2019-03-07 | 2018-12-31 | -0.45 | -0.5 | -0.05 | 11 | ||
2018-11-08 | 2018-09-30 | -0.44 | -0.5 | -0.06 | 13 | ||
2018-08-14 | 2018-06-30 | -0.38 | -0.5 | -0.12 | 31 | ||
2018-05-10 | 2018-03-31 | -0.4 | -0.6 | -0.2 | 50 | ||
2018-03-26 | 2017-12-31 | -0.5 | -0.6 | -0.1 | 20 | ||
2017-11-07 | 2017-09-30 | -0.67 | -0.9 | -0.23 | 34 | ||
2017-08-23 | 2017-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2017-05-09 | 2017-03-31 | -0.07 | -0.07 | 0.0 | 0 | ||
2017-03-06 | 2016-12-31 | -0.07 | -0.07 | 0.0 | 0 | ||
2016-11-16 | 2016-09-30 | -0.08 | -0.1 | -0.02 | 25 | ||
2016-08-18 | 2016-06-30 | -0.09 | -0.09 | 0.0 | 0 | ||
2016-05-06 | 2016-03-31 | -0.07 | -0.1 | -0.03 | 42 |
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.844 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.